Zetri T 1.125gm Injection
Marketer
Novartis India Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Zetri T 1.125gm Injection
Zetri T 1.125gm Injection, a multifaceted antibacterial formulation, combats diverse bacterial infections. Its action inhibits microbial proliferation, thus curbing infection spread. Administration must always be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; premature cessation may compromise efficacy, necessitating completion of the full treatment course regardless of symptom improvement. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects warrant immediate medical attention. Seek immediate medical assistance for any allergic reaction (e.g., rash, pruritus, edema, dyspnea). Prior to commencing treatment, disclose all current medications and pre-existing conditions to your physician. This is especially important for pregnant or breastfeeding individuals. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Monitoring the treatment's impact may involve periodic laboratory tests and diagnostic procedures as determined by your doctor.
Uses of Zetri T 1.125gm Injection
Infections caused by bacteria
Major Benefits of Zetri T 1.125gm Injection:
Administering this medication will be performed by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Zetri T 1.125gm Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Zetri T 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Zetri T 1.125gm Injection works:
Ceftriaxone and Tazobactum, the components of Zetri T 1.125gm Injection, act synergistically. Ceftriaxone, a crucial antibiotic, disrupts bacterial cell wall synthesis, hindering their survival. The beta-lactamase inhibitor, Tazobactum, complements this by neutralizing bacterial defenses, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from combining Zetri T 1.125gm Injection with alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Zetri T, 1.125gm, is typically deemed safe for use during gestation. Preclinical trials using animal models revealed minimal or no harmful consequences to the fetus; nevertheless, research involving human subjects is currently insufficient.
Breast feedingCAUTION
Administering Zetri T 1.125gm Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Zetri T 1.125gm Injection may induce drowsiness, blurred vision, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zetri T 1.125gm Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Exercise caution when administering 1.125-gram Zetri T injections to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Zetri T 1.125-gram injections is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Zetri T 1.125gm Injection :
Omit a scheduled Zetri T 1.125gm Injection? Seek immediate medical advice.
Facts to Know About Zetri T 1.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently